Gadobutrol

Ranked #218 on the list Best Patient Health Record of All Time

0.00
Based on 0 votes

About Gadobutrol

  • Subjects:
  • Subject of:

Gadobutrol (INN) (Gd-DO3A-butrol) is a gadolinium-based MRI contrast agent (GBCA). It received marketing approval in Canada and in the United States. As of 2007, it was the only GBCA approved at 1.0 molar concentrations. Gadobutrol is marketed by Bayer Schering Pharma as Gadovist, and by Bayer HealthCare Pharmaceuticals as Gadavist.

Comment on Gadobutrol

Voters

There are no voters yet.